301239 Stock Overview
A specialized chain medical institution company, engages in the provision of ophthalmic general medical services in China. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Chengdu Bright Eye Hospital Group Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥47.05 |
52 Week High | CN¥87.98 |
52 Week Low | CN¥28.48 |
Beta | 0.90 |
1 Month Change | -4.66% |
3 Month Change | 53.21% |
1 Year Change | -44.17% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -10.75% |
Recent News & Updates
These 4 Measures Indicate That Chengdu Bright Eye Hospital Group (SZSE:301239) Is Using Debt Extensively
Dec 17After Leaping 25% Chengdu Bright Eye Hospital Group Co., Ltd. (SZSE:301239) Shares Are Not Flying Under The Radar
Nov 19Recent updates
These 4 Measures Indicate That Chengdu Bright Eye Hospital Group (SZSE:301239) Is Using Debt Extensively
Dec 17After Leaping 25% Chengdu Bright Eye Hospital Group Co., Ltd. (SZSE:301239) Shares Are Not Flying Under The Radar
Nov 19Chengdu Bright Eye Hospital (SZSE:301239) Seems To Use Debt Quite Sensibly
Aug 15Chengdu Bright Eye Hospital's (SZSE:301239) Upcoming Dividend Will Be Larger Than Last Year's
Jul 19Chengdu Bright Eye Hospital (SZSE:301239) Is Reinvesting At Lower Rates Of Return
Jul 18Returns On Capital At Chengdu Bright Eye Hospital (SZSE:301239) Paint A Concerning Picture
Apr 11Shareholder Returns
301239 | CN Healthcare | CN Market | |
---|---|---|---|
7D | -10.1% | -2.2% | -1.2% |
1Y | -44.2% | -7.7% | 11.8% |
Return vs Industry: 301239 underperformed the CN Healthcare industry which returned -7.7% over the past year.
Return vs Market: 301239 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
301239 volatility | |
---|---|
301239 Average Weekly Movement | 14.5% |
Healthcare Industry Average Movement | 8.3% |
Market Average Movement | 8.7% |
10% most volatile stocks in CN Market | 12.8% |
10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 301239's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 301239's weekly volatility has increased from 9% to 15% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 4,918 | Qiang Sun | www.purui.cn |
Chengdu Bright Eye Hospital Group Co., Ltd., a specialized chain medical institution company, engages in the provision of ophthalmic general medical services in China. Its ophthalmology institutions provide diagnosis, treatment, health care, and medical optometry for patients with ophthalmic diseases in the areas of refractive surgery, cataract, ophthalmology, fundus disease, glaucoma, strabismus and pediatric ophthalmology, lacrimal duct, cornea orbital disease, eye trauma, medical optometry, and other general ophthalmology diagnosis and treatment items. The company was formerly known as Chengdu Bright Eye Hospital Co., Ltd.
Chengdu Bright Eye Hospital Group Co., Ltd. Fundamentals Summary
301239 fundamental statistics | |
---|---|
Market cap | CN¥7.26b |
Earnings (TTM) | -CN¥33.49m |
Revenue (TTM) | CN¥2.69b |
2.6x
P/S Ratio-209.2x
P/E RatioIs 301239 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
301239 income statement (TTM) | |
---|---|
Revenue | CN¥2.69b |
Cost of Revenue | CN¥1.54b |
Gross Profit | CN¥1.15b |
Other Expenses | CN¥1.18b |
Earnings | -CN¥33.49m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.22 |
Gross Margin | 42.83% |
Net Profit Margin | -1.25% |
Debt/Equity Ratio | 26.4% |
How did 301239 perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield-174%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 17:29 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Chengdu Bright Eye Hospital Group Co., Ltd. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jiaqi Xu | Citic Securities Co., Ltd. |
Yuan Yuan Sun | Industrial Securities Co. Ltd. |